Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation

Cell

Volumn 73, Issue 3, 1993, Pages 431-445

  Banner, David W ^a   D'Arcy, Allan ^a   Janes, Wolfgang ^a   Gentz, Reiner ^a   Schoenfeld, Hans Joachim ^a   Broger, Clemens ^a   Loetscher, Hansruedi ^a   Lesslauer, Werner ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LIGAND; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FOLDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; COMPARATIVE STUDY; HUMAN; LIGANDS; LYMPHOTOXIN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CELL SURFACE; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; X-RAY DIFFRACTION;

EID: 0027211704     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(93)90132-A     Document Type: Article

References (61)

1. The Protein Data Bank: a computer-based archival file for macromolecular structures
2. Identity of tumor necrosis factor and the macrophage secreted factor cachectin
3. Cytoplasmic truncation of the p55 tumor necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor
4. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures
5. Crystallographic R factor refinement by molecular dynamics
6. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family
7. Ribbon models of macromolecules
8. An endotoxin induced serum factor that causes necrosis of turnors
9. The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases
10. The crystal structure of erabutoxin A at 2.0 Å resolution
11. The fast rotation function
12. Crystallization and preliminary crystallographic analysis of TNF-β and a TNF-β-55 kDa TNF receptor complex
13. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences
14. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex
15. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
16. The structure of tumor necrosis factor alpha at 2.6 Å resolution: implications for receptor binding
17. The structure of human lymphotoxin (tumor necrosis factor beta) at 1.9 Å resolution
18. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity
19. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor
20. MERLOT an integrated package of computer programs for the determination of crystal structures by molecular replacement
21. Rational design of potent antagonists to the human growth hormone receptor
22. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation
23. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumor necrosis factor beta (lymphotoxin)
24. Three-dimensional pattern recognition: an approach to automated interpretation of electron density maps of proteins
25. Crystallization and preliminary X-ray investigation reveals that tumor necrosis factor is a compact trimer furnished with 3-fold symmetry
26. The p70 tumor necrosis factor receptor mediates cytotoxicity
27. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
28. Structure of tumor necrosis factor
29. Interactive computer graphics: FRODO
30. Improved methods for building protein models in electron density maps and the location of errors in these models
31. Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector
32. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF
33. A rotational search procedure for detecting a known molecule in a crystal
34. The interpretation of protein structures: estimation of static accessibility
35. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
36. Two distinct tumor necrosis factor receptors: members of a new cytokine receptor gene family
37. Recombinant 55 kDa TNF receptor stoichiometry of binding to TNFα and TNFβ and inhibition of TNF activity
38. Assessment of protein models with three-dimensional profiles
39. The growth and preliminary investigation of protein and nucleic acid crystals for X-ray diffraction analysis
40. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization
41. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily
42. Tumor necrosis factor (TNF)
43. Isolation and characterisation of a tumor necrosis factor binding protein from urine
44. Lymphotoxin
45. A stereo cartoon drawing program for proteins
46. Improved Fourier coefficients for maps using phases from partial structures with errors
47. Molecular cloning and expression of a receptor for human tumor necrosis factor
48. Efficient purification of recombinant human tumor necrosis factor beta from E. coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors
49. Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities
50. Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate
51. Conformations of β-hairpins in protein structures
52. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
53. The use of phase combination in crystallographic refinement the choice of amplitude coefficients in combined syntheses
54. The two different receptors for tumor necrosis factor mediate distinct cellular responses
55. Tumor necrosis factor signaling: a dominant negative mutation suppresses the activation of the 55 kDa tumor necrosis factor receptor
56. Signal transduction by receptors with tyrosine kinase activity
57. Localisation of the active site of human tumor necrosis factor (hTNF) by mutational analysis
58. 2.2 Å resolution structure analysis of two refined N-acetylneuraminyllactose: wheat germ agglutinin isolectin complexes
59. Mutational analysis of structure-activity relationships in human tumor necrosis factor alpha